E
Evi Lianidou
Researcher at National and Kapodistrian University of Athens
Publications - 203
Citations - 8268
Evi Lianidou is an academic researcher from National and Kapodistrian University of Athens. The author has contributed to research in topics: Circulating tumor cell & Cancer. The author has an hindex of 50, co-authored 181 publications receiving 7035 citations. Previous affiliations of Evi Lianidou include Toronto Western Hospital.
Papers
More filters
Journal ArticleDOI
Molecular Characterization of Circulating Tumor Cells in Breast Cancer by a Liquid Bead Array Hybridization Assay
TL;DR: A multiplexed PCR-coupled liquid bead array developed to detect the expression of multiple genes in CTCs can be measured simultaneously and reliably, thereby saving precious sample and reducing the costs and time of analysis.
Journal ArticleDOI
Presence of high-risk human papillomavirus sequences in breast cancer tissues and association with histopathological characteristics
TL;DR: The presence of high-risk HPV DNA sequences in the breast cancer tissues studied was verified, and a possible association with acceleration of malignancy was examined.
Journal ArticleDOI
ESR1 Methylation: A Liquid Biopsy–Based Epigenetic Assay for the Follow-up of Patients with Metastatic Breast Cancer Receiving Endocrine Treatment
Sophia Mastoraki,Areti Strati,Eleni Tzanikou,Maria Chimonidou,Eleni Politaki,Alexandra Voutsina,Amanda Psyrri,Vassilis Georgoulias,Evi Lianidou +8 more
TL;DR: ESR1 methylation in CTCs was associated with lack of response to everolimus/exemestane regimen and should be further evaluated as a potential liquid biopsy-based biomarker.
Journal ArticleDOI
Hypoxia-inducible factor-1α and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients
Galatea Kallergi,Harris Markomanolaki,Vicky Giannoukaraki,Maria Papadaki,Areti Strati,Evi Lianidou,Vassilis Georgoulias,Dimitris Mavroudis,Sofia Agelaki +8 more
TL;DR: The expression of pFAK, HIF-1α, V EGF and VEGF2 in CTCs of patients with metastatic breast cancer could explain the metastatic potential of these cells and may provide a therapeutic target for their elimination.
Journal ArticleDOI
Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer
N. Xenidis,Ioannis G. Vlachonikolis,Dimitris Mavroudis,M. Perraki,Aliki Stathopoulou,N. Malamos,Charalambos Kouroussis,S. Kakolyris,Stella Apostolaki,N. Vardakis,Evi Lianidou,Vassilis Georgoulias +11 more
TL;DR: The detection of CK-19 mRNA-positive cells in the peripheral blood after adjuvant chemotherapy may be of clinical relevance for patients with early breast cancer and less than four involved axillary lymph nodes.